Cowen and Company’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Cowen and Company’s Portfolio FLACW Stock Details FLACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-124,551	Closed	-$10K	–	833
2022 Q2	$10K	Buy	124,551 +9,942	+9%	+$1.73K	﹤0.01%	493
2022 Q1	$26K	Sell	114,609 -44,978	-28%	-$19.5K	﹤0.01%	403
2021 Q4	$94K	Buy	159,587 +125,953	+374%	+$87.9K	0.01%	378
2021 Q3	$23K	Buy	+33,634	New	+$30.2K	﹤0.01%	477

Other funds holding FLACW

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

HCM

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

ETH

Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

CCA

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return

Cowen and Company's FLACW Position: Q3 2022 in Review

Cowen and Company sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q3 2022, closing a stake of 124,551 shares — an estimated $10K sold.

Cowen and Company first reported a position in FLACW in Q3 2021 and held it in 4 quarters. The position peaked at $94K in Q4 2021. 21 funds tracked by Wall St. Rank hold FLACW as of Q3 2022.

Cowen and Company reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q3 2022 after selling out during the quarter.
Cowen and Company sold 124,551 Frazier Lifesciences Acquisition Corporation Warrant shares in Q3 2022, an estimated $10K.
Cowen and Company first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q3 2021 and held it in 4 quarters.
Cowen and Company's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $94K in Q4 2021.
21 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q3 2022.

Based on Cowen and Company's 13F filing for Q3 2022, filed 14 Nov 2022.